155 related articles for article (PubMed ID: 9840913)
21. Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
Roberts JD; Smith MR; Feldman EJ; Cragg L; Grant S
Clin Lymphoma; 2002 Dec; 3(3):184-8. PubMed ID: 12521398
[No Abstract] [Full Text] [Related]
22. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
Palomera L; Azaceta G; Varo MJ; Soria J; Gutierrez M
Haematologica; 1998 Nov; 83(11):1045-6. PubMed ID: 9864929
[TBL] [Abstract][Full Text] [Related]
23. Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience.
Montserrat E; Lopez-Lorenzo JL; Manso F; Martin A; Prieto E; Arias-Sampedro J; Fernandez MN; Oyarzabal FJ; Odriozola J; Alcala A; Garcia-Conde J; Guardia R; Bosch F
Leuk Lymphoma; 1996 May; 21(5-6):467-72. PubMed ID: 9172812
[TBL] [Abstract][Full Text] [Related]
24. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
25. Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia.
Weiss RB; Freiman J; Kweder SL; Diehl LF; Byrd JC
J Clin Oncol; 1998 May; 16(5):1885-9. PubMed ID: 9586905
[TBL] [Abstract][Full Text] [Related]
26. High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma.
Summerfield GP; Taylor PR; Mounter PJ; Proctor SJ
Br J Haematol; 2002 Mar; 116(4):781-6. PubMed ID: 11886381
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia.
Montillo M; Tedeschi A; Leoni P
Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499
[No Abstract] [Full Text] [Related]
28. Listeriosis after fludarabine treatment for chronic lymphocytic leukemia.
Hequet O; de Jaureguiberry JP; Jaubert D; Gisserot O; Muzellec Y; Brisou P
Hematol Cell Ther; 1997 Apr; 39(2):89-91. PubMed ID: 9168306
[TBL] [Abstract][Full Text] [Related]
29. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
30. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Binet JL
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas.
Fenchel K; Bergmann L; Wijermans P; Engert A; Pralle H; Mitrou PS; Diehl V; Hoelzer D
Leuk Lymphoma; 1995 Aug; 18(5-6):485-92. PubMed ID: 8528057
[TBL] [Abstract][Full Text] [Related]
32. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
33. [Fludarabine and fatal hemolytic anemia].
López L; del Villar V; Pascual T
Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
[No Abstract] [Full Text] [Related]
34. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
[TBL] [Abstract][Full Text] [Related]
35. Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
Sen K; Kalaycio M
Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320
[No Abstract] [Full Text] [Related]
36. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
Tam C; Seymour JF; Brown M; Campbell P; Scarlett J; Underhill C; Ritchie D; Bond R; Grigg AP
Haematologica; 2005 May; 90(5):700-2. PubMed ID: 15921393
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced immune hemolytic anemia.
Garratty G
Clin Adv Hematol Oncol; 2010 Feb; 8(2):98-101. PubMed ID: 20386530
[No Abstract] [Full Text] [Related]
38. [Progressive multifocal leukoencephalopathy in a patient with chronic lymphatic leukemia treated with fludarabine].
Mata MI; Gardella S; del Mar Castellanos M; Ortiz MR
Med Clin (Barc); 2000 Nov; 115(15):598-9. PubMed ID: 11141397
[No Abstract] [Full Text] [Related]
39. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
40. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
Field K; Slavin MA; Seymour JF
Eur J Haematol; 2002 Jul; 69(1):54-7. PubMed ID: 12270063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
